Literature DB >> 31968249

The Mitochondrial Protein MAVS Stabilizes p53 to Suppress Tumorigenesis.

Wanchuan Zhang1, Jing Gong2, Huan Yang3, Luming Wan4, Yumeng Peng3, Xiaolin Wang4, Jin Sun4, Feng Li4, Yunqi Geng4, Dongyu Li4, Ning Liu4, Gangwu Mei5, Yuan Cao6, Qiulin Yan7, Huilong Li3, Yanhong Zhang4, Xiang He4, Qiaozhi Zhang4, Rui Zhang8, Feixiang Wu9, Hui Zhong10, Congwen Wei11.   

Abstract

Recent reports have shown the critical role of the mitochondrial antiviral signaling (MAVS) protein in virus-induced apoptosis, but the involvement of MAVS in tumorigenesis is still poorly understood. Herein, we report that MAVS is a key regulator of p53 activation and is critical for protecting against tumorigenesis. We find that MAVS promotes p53-dependent cell death in response to DNA damage. MAVS interacts with p53 and mediates p53 mitochondrial recruitment under genotoxic stress. Mechanistically, MAVS inhibits p53 ubiquitination by blocking the formation of the p53-murine double-minute 2 (MDM2) complex, leading to the stabilization of p53. Notably, compared with their wild-type littermates, MAVS knockout mice display decreased resistance to azoxymethane (AOM) or AOM/dextran sulfate sodium salt (DSS)-induced colon cancer. MAVS expression is significantly downregulated in human colon cancer tissues. These results unveil roles for MAVS in DNA damage response and tumor suppression.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MAVS; p53; tumor suppression; ubiquitination

Mesh:

Substances:

Year:  2020        PMID: 31968249     DOI: 10.1016/j.celrep.2019.12.051

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  8 in total

1.  Intestinal Bacterial Translocation Contributes to Diabetic Kidney Disease.

Authors:  Hoang Thuy Linh; Yasunori Iwata; Yasuko Senda; Yukiko Sakai-Takemori; Yusuke Nakade; Megumi Oshima; Shiori Nakagawa-Yoneda; Hisayuki Ogura; Koichi Sato; Taichiro Minami; Shinji Kitajima; Tadashi Toyama; Yuta Yamamura; Taro Miyagawa; Akinori Hara; Miho Shimizu; Kengo Furuichi; Norihiko Sakai; Hiroyuki Yamada; Katsuhiko Asanuma; Kouji Matsushima; Takashi Wada
Journal:  J Am Soc Nephrol       Date:  2022-03-09       Impact factor: 14.978

2.  The Role of REC8 in the Innate Immune Response to Viral Infection.

Authors:  Shengwen Chen; Qian Liu; Lini Zhang; Jiahuan Ma; Binbin Xue; Huiyi Li; Rilin Deng; Mengmeng Guo; Yan Xu; Renyun Tian; Jingjing Wang; Wenyan Cao; Qiong Yang; Luolin Wang; Xinran Li; Shun Liu; Di Yang; Haizhen Zhu
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

3.  The Critical Role Played by Mitochondrial MITF Serine 73 Phosphorylation in Immunologically Activated Mast Cells.

Authors:  Lakshmi Bhargavi Paruchuru; Sharmila Govindaraj; Ehud Razin
Journal:  Cells       Date:  2022-02-08       Impact factor: 6.600

4.  DNA damage alters EGFR signaling and reprograms cellular response via Mre-11.

Authors:  Yael Volman; Ruth Hefetz; Eithan Galun; Jacob Rachmilewitz
Journal:  Sci Rep       Date:  2022-04-06       Impact factor: 4.379

5.  Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression.

Authors:  Bin-Jin Hwang; Li-Chung Tsao; Chaitanya R Acharya; Timothy Trotter; Pankaj Agarwal; Junping Wei; Tao Wang; Xiao-Yi Yang; Gangjun Lei; Takuya Osada; Herbert Kim Lyerly; Michael A Morse; Zachary Conrad Hartman
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469

6.  Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers.

Authors:  Mehmet Arda Temena; Ahmet Acar
Journal:  Sci Rep       Date:  2022-08-15       Impact factor: 4.996

Review 7.  The role of ubiquitination and deubiquitination in cancer metabolism.

Authors:  Tianshui Sun; Zhuonan Liu; Qing Yang
Journal:  Mol Cancer       Date:  2020-10-01       Impact factor: 27.401

8.  COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention.

Authors:  Ashif Iqubal; Mohammad Kashif Iqubal; Farazul Hoda; Abul Kalam Najmi; Syed Ehtaishamul Haque
Journal:  Expert Rev Anti Infect Ther       Date:  2021-03-05       Impact factor: 5.091

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.